Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1

Código QR

Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1

The response to neoadjuvant immune checkpoint blockade (ICB) in patients with recurrent gliolastoma multiforme (GBM) has been challenging to interpret. Here the authors develop a tumor analysis framework that reveals molecular similarities between GBM and melanoma and unique patterns of immunosuppre...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yue Lu, Alphonsus H. C. Ng, Frances E. Chow, Richard G. Everson, Beth A. Helmink, Michael T. Tetzlaff, Rohit Thakur, Jennifer A. Wargo, Timothy F. Cloughesy, Robert M. Prins, James R. Heath
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/da58c67153ba43c0bfe64ab0eaad9f67
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
por: Alexander H. Lee, et al.
Publicado: (2021)

Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
por: Ya-Dan Wen, et al.
Publicado: (2021)

"There Will Not Always Be Teachers Like This": For G.B.M.
por: David Jardine
Publicado: (2016)

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
por: Nina Radosevic-Robin, et al.
Publicado: (2021)

Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy
por: Yushi Nagaki, et al.
Publicado: (2021)

Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma
por: Elena Galvani, et al.
Publicado: (2020)

Experimental Analysis of GBM to Expand the Time Horizon of Irish Electricity Price Forecasts
por: Conor Lynch, et al.
Publicado: (2021)

Automatic Search of Cataclysmic Variables Based on LightGBM in LAMOST-DR7
por: Zhiyuan Hu, et al.
Publicado: (2021)

14-3-3ζ negatively regulates mitochondrial biogenesis in GBM residual cells
por: Jacinth Rajendra, et al.
Publicado: (2021)

Selection of Outline Descriptors Based on LightGBM with Application to Infrared Image Target Recognition
por: Xiaohong Hu, et al.
Publicado: (2021)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
por: Po-Han Lin, et al.
Publicado: (2021)

Surprisal analysis of Glioblastoma Multiform (GBM) microRNA dynamics unveils tumor specific phenotype.
por: Sohila Zadran, et al.
Publicado: (2014)

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
por: Mark Jesus M. Magbanua, et al.
Publicado: (2021)

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy
por: Sjoerd H van der Burg, et al.
Publicado: (2021)

Memory consolidation and improvement by synaptic tagging and capture in recurrent neural networks
por: Jannik Luboeinski, et al.
Publicado: (2021)

Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).
por: Juan Li, et al.
Publicado: (2013)

Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
por: Chuanliang Cui, et al.
Publicado: (2021)

MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy.
por: Ella F Jones, et al.
Publicado: (2013)

A Two-Stage Multistep-Ahead Electricity Load Forecasting Scheme Based on LightGBM and Attention-BiLSTM
por: Jinwoong Park, et al.
Publicado: (2021)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Seung Ho Song, et al.
Publicado: (2021)

Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer
por: Barak Rosenzweig, et al.
Publicado: (2021)

Evaluation of PD-L1 and tumor infiltrating lymphocytes in paired pretreatment biopsies and post neoadjuvant chemotherapy surgical specimens of breast carcinoma
por: Lucas Grecco Hoffmann, et al.
Publicado: (2021)

PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
por: Kensuke Kojima, et al.
Publicado: (2021)

Correction: Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis
Publicado: (2021)

Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
por: Ghada M. Salum, et al.
Publicado: (2021)

Effect of MHC Linked 7-Gene Signature on Delayed Hepatocellular Carcinoma Recurrence
por: Fomaz Tariq, et al.
Publicado: (2021)

Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Kai Yang, et al.
Publicado: (2017)

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
por: Yu-Hsiang Chen, et al.
Publicado: (2017)

Characteristics and Risk Factors of Postoperative Complications in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
por: SUN Chongyuan, et al.
Publicado: (2021)

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
por: Jennifer L. Caswell-Jin, et al.
Publicado: (2019)

A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
por: Chen Qiang, et al.
Publicado: (2021)

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients
por: Ina P. Pavlova, et al.
Publicado: (2021)

[2] Neoadjuvant intravesical chemotherapy to treat extended large non-muscle-invasive bladder cancer
por: Marco Raber, et al.
Publicado: (2018)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Su Han Cho, et al.
Publicado: (2021)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang G, et al.
Publicado: (2021)

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
por: Jennifer L. Caswell-Jin, et al.
Publicado: (2019)

Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis
por: Xiaofei Wang, et al.
Publicado: (2021)

ETS transcription factors induce a unique UV damage signature that drives recurrent mutagenesis in melanoma
por: Peng Mao, et al.
Publicado: (2018)

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
por: M. Liontos, et al.
Publicado: (2021)

Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
por: Sarah J. Dart, et al.
Publicado: (2021)